Gene Therapies Come to Saudi Arabia for 500,000 Patients

A groundbreaking partnership will bring one-time gene therapies for sickle cell disease and beta-thalassemia to Saudi Arabia and the Middle East, where over 500,000 people live with these genetic blood disorders.

Local manufacturing will make these life-changing treatments more accessible to patients who desperately need them.